A.在治疗期第一天,在给药前(基线)、给药后1,2,3,4,5,6,8,10,12小时(时间窗±15min)分别进行FEV1的测量 B.在治疗期第一天,在给药前(给药前30min内)和用药后第0.5 h(±5min)、1 h(±10min)、2 h(±10min)、3 h(±15min)、4 h(±15min)、6 h(±30min)、8 h(±30min)、10 h(±...
FEV1 AUC0–12 and AUC12–24 responses with both QD olodaterol doses and BID formoterol were significantly greater than placebo at 6 weeks (P < .0001). Secondary end-point outcomes were consistent with those of the co-primary end points. These data, together with those from the wider phase...